ArticlePloS one2025
The burden of HIV/AIDS in Ethiopia: Unveiling 30 years of trends in incidence, mortality, and disability-insights from the Global Burden of Disease study (1990-2021).
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Tigray War and HIV Care Cascade Entry in Mekelle, Ethiopia.JAMA network open · 2026Article
- Article
- Undernutrition and Associated Factors Among Adults on Second-Line Antiretroviral Therapy in Debark, Ethiopia: A Cross-Sectional Study.Journal of the International Association of Providers of AIDS CareArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver the past three decades, Ethiopia has witnessed a dynamic shift in the burden of HIV/AIDS, a public health crisis that has profoundly impacted communities nationwide. While significant strides have been made in combating the disease, evolving trends in incidence, mortality, and disability reveal the complexity of progress. The insights drawn from the Global Burden of Disease Study (1990-2021) offer a comprehensive perspective on the successes and ongoing challenges. Understanding these trends is critical for refining public health strategies and achieving more equitable health outcomes. This study delves into the data, unveiling key findings that inform future policies and interventions.
methodsThis study used data from the 2021 Global Burden of Disease Study (1990-2021) to evaluate HIV/AIDS incidence, mortality, and DALYs in Ethiopia. The dataset, including age-standardized rates and 95% uncertainty intervals, was obtained from the Global Health Data Exchange (GHDx). Statistical analyses included Joinpoint regression to identify trend shifts and calculate the Annual and Average Annual Percentage Change over time, with significance determined at a p-value of 0.05. Geographic variations were visualized using ArcGIS Pro, highlighting regions with varying HIV burdens. The comprehensive methodology adhered to GATHER guidelines for transparent reporting.
resultsIn 2021, 715,839 individuals (95% UI: 568,889.58-914,511.59) were living with HIV in Ethiopia, and 839,819.31 DALYs (95% UI: 620,558.56-1,154,483.92) were recorded. There was a significant decline in the age-standardized HIV incidence rate, from 175.4 per 100,000 in 1990 to 22.4 per 100,000 in 2021, with an average annual percentage change (AAPC) of -6.64% (p < 0.001). Mortality rates rose from 14.2 per 100,000 in 1990 to 79.7 in 2000 but decreased to 13.6 by 2021, with an AAPC of -1.19%. DALYs peaked in 2010 at 1,695.1 per 100,000 and declined to 770.9 per 100,000 in 2021, with an AAPC of -1.43%. Higher incidence (28.1) and mortality (17.7) were observed in females compared to males (16.7 and 9.6). The Gambela region reported the highest burden, with an incidence rate of 176.3 per 100,000, a mortality rate of 78.4 per 100,000, and 4,220.7 DALYs per 100,000.
conclusionEthiopia accounts for 1.8% of the global HIV/AIDS prevalence. While significant progress has been made in recent years, sustained efforts are necessary to further reduce the burden of the disease. The disproportionate impact on females and the Gambela region underscores persistent disparities in prevention and care. To achieve equitable health outcomes across the country, it is crucial to implement targeted, evidence-based interventions that address these gaps in the HIV/AIDS response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.